Figure 1
Figure 2
Figure 3
Figure 4
The dynamics of lipid profile modifications under the association of statin and PCSK9 inhibitor (comparison between the levels of the lipid profile during hospitalisation and at 1 month follow-up)
| Parameter | Atorvastatin | Atorvastatin 20 mg + Alirocumab 150 mg | 4 weeks after association of treatment |
|---|---|---|---|
| Total Cholesterol | 226 mg/dl | 110 mg/dl | −52% |
| LDL-C | 178 mg/dl | 58 mg/dl | −68% |
| HDL-C | 28 mg/dl | 39 mg/dl | +40% |
| Triglycerides | 104 mg/dl | 81 mg/dl | −22% |